Marleen van de Beek
Overview
Explore the profile of Marleen van de Beek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dubbelman M, van de Beek M, van Gils A, Leeuwis A, van der Vlies A, Pijnenburg Y, et al.
J Int Neuropsychol Soc
. 2024 Sep;
30(9):867-874.
PMID: 39297182
Objectives: We aimed to compare and link the total scores of the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA), two common global cognitive screeners. Methods: 2,325 memory clinic...
2.
Coomans E, de Koning L, Rikken R, Verfaillie S, Visser D, den Braber A, et al.
Neurology
. 2023 Sep;
101(19):e1850-e1862.
PMID: 37748892
Background And Objectives: Recently, the US Food and Drug Administration approved the tau-binding radiotracer [F]flortaucipir and an accompanying visual read method to support the diagnostic process in cognitively impaired patients...
3.
Inguanzo A, Poulakis K, Mohanty R, Schwarz C, Przybelski S, Diaz-Galvan P, et al.
NPJ Parkinsons Dis
. 2023 Jan;
9(1):5.
PMID: 36670121
Dementia with Lewy bodies (DLB) is a neurodegenerative disorder with a wide heterogeneity of symptoms, which suggests the existence of different subtypes. We used data-driven analysis of magnetic resonance imaging...
4.
van Gils A, van de Beek M, van Unnik A, Tolonen A, Handgraaf D, van Leeuwenstijn M, et al.
Alzheimers Dement (Amst)
. 2022 Dec;
14(1):e12379.
PMID: 36569383
Introduction: Distinguishing dementia with Lewy bodies (DLB) from Alzheimer's disease (AD) is challenging due to overlapping presentations. We adapted a Web-based test tool, cCOG, by adding a visuospatial task and...
5.
van de Beek M, van Unnik A, van Steenoven I, van der Zande J, Barkhof F, Teunissen C, et al.
Int J Geriatr Psychiatry
. 2022 Nov;
37(12).
PMID: 36403133
Background And Objectives: Dementia with Lewy Bodies (DLB) is a heterogeneous disease, with variable signs and symptoms across multiple domains. We aimed to identify associations with rate of change in...
6.
van de Beek M, Ooms F, Ebenau J, Barkhof F, Scheltens P, Teunissen C, et al.
Neurology
. 2022 Jan;
98(12):e1262-e1272.
PMID: 35074893
Background And Objectives: The ATN framework has been developed to categorize biological processes within the Alzheimer disease (AD) continuum. Because AD pathology often coincides with dementia with Lewy bodies (DLB),...
7.
Abdelnour C, Ferreira D, van de Beek M, Cedres N, Oppedal K, Cavallin L, et al.
Alzheimers Res Ther
. 2022 Jan;
14(1):14.
PMID: 35063023
Background: Dementia with Lewy bodies (DLB) includes various core clinical features that result in different phenotypes. In addition, Alzheimer's disease (AD) and cerebrovascular pathologies are common in DLB. All this...
8.
Bakker E, van Maurik I, Mank A, Zwan M, Waterink L, van den Buuse S, et al.
J Alzheimers Dis
. 2022 Jan;
86(2):931-939.
PMID: 35034903
Background: The COVID-19 pandemic poses enormous social challenges, especially during lockdown. People with cognitive decline and their caregivers are particularly at risk of lockdown consequences. Objective: To investigate psychosocial effects...
9.
Genetics Contributes to Concomitant Pathology and Clinical Presentation in Dementia with Lewy Bodies
van der Lee S, van Steenoven I, van de Beek M, Tesi N, Jansen I, van Schoor N, et al.
J Alzheimers Dis
. 2021 Jul;
83(1):269-279.
PMID: 34308904
Background: Dementia with Lewy bodies (DLB) is a complex, progressive neurodegenerative disease with considerable phenotypic, pathological, and genetic heterogeneity. Objective: We tested if genetic variants in part explain the heterogeneity...
10.
Rossi M, Baiardi S, Teunissen C, Quadalti C, van de Beek M, Mammana A, et al.
Neurology
. 2021 Jul;
97(9):e930-e940.
PMID: 34210822
Objective: To investigate whether the CSF α-synuclein (α-syn) real-time quaking-induced conversion (RT-QuIC) assay accurately identifies patients with mild cognitive impairment (MCI) due to probable Lewy body (LB) disease. Methods: We...